Specialty finance company focused on acquiring life settlements and providing capital solutions to the life settlement market.
SWK Holdings Corporation operates as a specialized finance company primarily focused on the healthcare sector, leveraging its expertise across two main segments: Finance Receivables and Pharmaceutical Development. Founded in 1996 and headquartered in Dallas, Texas, the company provides tailored financing solutions to a diverse array of life science companies, including those in biotechnology, medical devices, diagnostics, animal health, and pharmaceuticals. These solutions cater not only to established enterprises but also to institutions and inventors seeking capital for research, development, and commercialization of healthcare innovations.
In addition to its financing activities, SWK Holdings Corporation engages in pharmaceutical development through its Peptelligence platform. This initiative involves formulation, manufacturing, and licensing of pharmaceutical products, with a notable pipeline featuring Ovarest, an oral leuprolide tablet designed to treat endocrine diseases. Beyond financial services, the company also offers non-discretionary investment advisory services, managing separate accounts for institutional clients focused on life science finance. This multifaceted approach underscores SWK Holdings' commitment to fostering innovation and advancement within the healthcare industry, aiming to bridge critical gaps in funding and accelerate the delivery of new medical solutions to market.
As SWK Holdings Corporation continues to expand its footprint in healthcare finance and pharmaceutical development, it remains dedicated to driving growth and value creation for its stakeholders. By combining strategic investment with proprietary development capabilities, the company plays a pivotal role in supporting the lifecycle of healthcare innovations from concept to commercialization. With a strong foundation built on decades of industry experience and a forward-looking approach to financial and scientific innovation, SWK Holdings is poised to navigate and thrive in the evolving landscape of healthcare finance and pharmaceutical development.